Skip to content

Comparison of effect of Arka Taila (oil) and Arka Malahar (ointment) on Vicharchika (skin disease) for external application

A RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF ARKA TAILA ALONG WITH ARKA MALAHAR AS TOPICAL APPLICATION IN THE MANAGEMENT OF VICHARCHIKA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051024
Enrollment
60
Registered
2023-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Sponsors

DR BHAGAWAN GOPALGHARE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients will be selected irrespective of sex and socio economic status 2 Patients between the age group of 18 to 70yrs will be included in the study 3 Patients with complaints of Kandu Pidika Raji Shyava Rukshata Utsedh itching pustules discolouration dryness swelling

Exclusion criteria

Exclusion criteria: 1 Patients on steroid ointments 2 Patients having other skin disease like leprosy lichen planus 3 Patient with symptoms like redness pustules vesicle

Design outcomes

Primary

MeasureTime frame
1 To evaluate the efficacy of ArkaMalahara in the management of Vicharchika 2 To evaluate the efficacy of ArkaTaila in the management of Vicharchika 3 To compare the efficacy of ArkaTaila and ArkaMalahara in the management of Vicharchika Timepoint: Follow up will be on 15th day

Secondary

MeasureTime frame
1 To Study The Adverse Effect Of Arka Malhar 2 To compare the efficacy of ArkaTaila and ArkaMalahara in the management of Vicharchika Timepoint: Follow up will be on 15th days

Countries

India

Contacts

Public ContactDR BHAGAWAN GOPALGHARE

Dr D Y Patil College of Ayurved and Research Centre

sachinrohani1985@gmail.com9730490300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026